Finance JournalistFinance journalist at Grafa. Covers tech, crypto, and markets, making complex finance clear for all. Passionate about innovation and trends.
Novo Nordisk (NYSE:NVO) today announced that the U.S. Food and Drug Administration (FDA) has approved Awiqli® (insulin icodec-abae), the first and only once-weekly, long-acting basal insulin for adults living with type 2 diabetes.
Pharming Group (NASDAQ:PHAR), a global biopharmaceutical company dedicated to transforming the lives of patients with rare diseases, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has adopted a positive opinion.
Binance is seeking an out-of-court settlement with Nigerian authorities over a $2 billion tax dispute, signalling a potential resolution to one of its largest legal battles.
A US federal judge has temporarily blocked the Pentagon’s ban on AI firm Anthropic, halting efforts to restrict government use of its Claude chatbot.
Fenbushi Capital co-founder Bo Shen has offered a bounty of up to 20% to recover $42 million in crypto stolen from his personal wallet in a 2022 hack.
Wall Street firms are unlikely to adopt fully transparent public blockchains, with DRW CEO Don Wilson arguing that open ledgers conflict with how institutions manage risk and execute trades.
The debate over whether Bitcoin can replace gold as a safe-haven asset has resurfaced during the Iran conflict, but analysts warn it is too early to draw conclusions.
Radiopharm Theranostics (ASX:RAD) has dosed the first patient in its Phase 1 clinical trial of RAD 402.
Innate Pharma (NASDAQ:IPHA), a clinical-stage biotechnology company developing next-generation immunotherapies for cancer, today reported its consolidated financial results for the full year ended December 31, 2025.
The Australian Agricultural Company (ASX:AAC) released a critical update regarding the 2025/2026 monsoon flooding.
